Larissa A. Pikor
675 West 10th Ave, V5Z 1L3
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Journal: Frontiers in immunology
Published: August 27, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Journal: Nature communications
Published: November 11, 2021
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.
Journal: Journal for immunotherapy of cancer
Published: February 01, 2018
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.
Journal: Science translational medicine
Published: August 21, 2017
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
Journal: Epigenomics
Published: April 21, 2016
Macrophages, Inflammation, and Lung Cancer.
Journal: American journal of respiratory and critical care medicine
Published: November 20, 2015
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil.
Journal: Trends in cancer
Published: September 08, 2015
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
Journal: The Journal of pathology
Published: September 04, 2015
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.
Journal: Molecular oncology
Published: August 28, 2015
Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.
Journal: International journal of cancer
Published: July 19, 2014
Last Updated: 09/26/2026